Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rang in Aktien #18713
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Aktienkurs
$2.49
Marktkapitalisierung
$4.47M
Veränderung (1 Tag)
-4.01%
Veränderung (1 Jahr)
678.16%
Land
MY
Handel BioNexus Gene Lab Corporation (BGLC)

Kategorie

Dividendenrendite-Verlauf für BioNexus Gene Lab Corporation (BGLC)
Dividendenrendite (TTM) von BioNexus Gene Lab Corporation (Aktienkürzel: BGLC) zum 2023-12-31: 0.00%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für BioNexus Gene Lab Corporation (BGLC) von 2016 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber